Lilly Just Dropped Zepbound Prices – Is This the Start of a GLP-1 Price War? скачать в хорошем качестве

Lilly Just Dropped Zepbound Prices – Is This the Start of a GLP-1 Price War?

Major Price Decrease for Zepbound: A Game Changer in Obesity Treatment? In this episode of 'The Downsized,' Christopher Durham discusses Eli Lilly's recent price reductions for Zepbound vials, part of the GLP 1 medications used for obesity treatment. Christopher shares his and Laraine's weight loss journey using these medications and delves into the implications of Lilly's new pricing model aimed at increasing affordability. Despite skepticism about the impact, this move could signal the beginning of a pricing war in the obesity treatment market, potentially benefiting patients long term. Join the discussion tonight at 7 PM for further insights and updates. DOWNSIZED WEBSITE: https://thedownsized.org/ JOIN CLUB DOWNSIZED:    / @thedownsized   DOWNSIZED GLP-1 COMPANION PRODUCT STORE: https://thedownsized.org/downsized-store 00:00 Introduction and Personal Success Stories 00:53 Breaking News: Eli Lilly's Price Drop 01:13 Details on New Zepbound Offerings 03:04 Strategic Move Against Compounded Tirzepatide 04:52 Lilly Direct and Transparent Pricing 06:05 Impact on Medicare Patients and Affordability 06:47 The Bigger Picture: Market Implications 08:53 Conclusion and Upcoming Live Session